Literature DB >> 16810447

Angiographic segment size in patients referred for coronary intervention is influenced by constitutional, anatomical, and clinical features.

Pedro A Lemos1, Expedito E Ribeiro, Marco A Perin, Luiz J Kajita, Marco A de Magalhães, João L A A Falcão, Antonio Esteves Filho, Marcus N da Gama, Pedro E Horta, Gilberto G Marchiori, Andre G Spadaro, Eulógio E Martinez.   

Abstract

BACKGROUND: Factors influencing the size of target vessels of patients referred for coronary intervention are poorly defined. We aimed to investigate in a large series of patients undergoing percutaneous intervention the relation of constitutional, anatomical, and clinical features with the reference diameter of coronary vessels treated with stenting.
METHODS: A total of 4,850 de novo coronary lesions, non-ostial and non-bifurcational, located in native vessels were analyzed. The following pre-specified characteristics were analyzed to reflect the relation between constitutional, anatomical, and clinical features on reference vessel diameter: age, gender, height, weight, proximal location, vessel, diabetes, hypertension, multivessel disease, and clinical presentation.
RESULTS: The average reference diameter was 2.66+/-0.50 mm. All pre-specified markers had a significant relation with the vessel reference diameter at univariate analysis, except by hypertension which showed a strong tendency. However, at multivariate analysis, only diabetes, proximal location, multivessel disease, clinical presentation, vessel, weight, and height were identified as independent predictors of reference vessel diameter.
CONCLUSION: Reference diameter of coronary vessels at the site of lesions treated by stenting is significantly influenced by a variety of characteristics. We hypothesize that the treated segment size of patients undergoing stenting ultimately reflects the conjoint effect of several different factors, including constitutional, anatomical, and clinical features.

Entities:  

Mesh:

Year:  2006        PMID: 16810447     DOI: 10.1007/s10554-006-9119-2

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  24 in total

1.  Treatment of very small vessels with 2.25-mm diameter sirolimus-eluting stents (from the RESEARCH registry).

Authors:  Pedro A Lemos; Chourmouzios A Arampatzis; Francesco Saia; Angela Hoye; Muzaffer Degertekin; Kengo Tanabe; Chi-Hang Lee; Paul Cummins; Pieter C Smits; Eugène McFadden; Georgios Sianos; Pim de Feyter; Willem J van der Giessen; Ron T van Domburg; Patrick W Serruys
Journal:  Am J Cardiol       Date:  2004-03-01       Impact factor: 2.778

2.  Quantitative study on the size of coronary artery supplying areas postmortem.

Authors:  H Kalbfleisch; W Hort
Journal:  Am Heart J       Date:  1977-08       Impact factor: 4.749

3.  Sex differences in coronary artery size assessed by intravascular ultrasound.

Authors:  S E Sheifer; M R Canos; K P Weinfurt; U K Arora; F O Mendelsohn; B J Gersh; N J Weissman
Journal:  Am Heart J       Date:  2000-04       Impact factor: 4.749

4.  Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms.

Authors:  J H Reiber; P W Serruys; C J Kooijman; W Wijns; C J Slager; J J Gerbrands; J C Schuurbiers; A den Boer; P G Hugenholtz
Journal:  Circulation       Date:  1985-02       Impact factor: 29.690

Review 5.  Definition and measurement of restenosis after successful coronary angioplasty: implications for clinical trials.

Authors:  J Lespérance; M G Bourassa; L Schwartz; G Hudon; J Laurier; C Eastwood; F Kazim
Journal:  Am Heart J       Date:  1993-05       Impact factor: 4.749

6.  Angiographic findings of the multicenter Randomized Study With the Sirolimus-Eluting Bx Velocity Balloon-Expandable Stent (RAVEL): sirolimus-eluting stents inhibit restenosis irrespective of the vessel size.

Authors:  E Regar; P W Serruys; C Bode; C Holubarsch; J L Guermonprez; W Wijns; A Bartorelli; C Constantini; M Degertekin; K Tanabe; C Disco; E Wuelfert; M C Morice
Journal:  Circulation       Date:  2002-10-08       Impact factor: 29.690

7.  Abnormal epicardial coronary resistance in patients with diffuse atherosclerosis but "Normal" coronary angiography.

Authors:  B De Bruyne; F Hersbach; N H Pijls; J Bartunek; J W Bech; G R Heyndrickx; K L Gould; W Wijns
Journal:  Circulation       Date:  2001-11-13       Impact factor: 29.690

8.  Stenting vs. balloon angioplasty with provisional stenting for the treatment of vessels with small reference diameter.

Authors:  Pedro A Lemos; Eulogio E Martinez; Edgard Quintella; Lari C Harrell; Jose A F Ramires; Expedito E Ribeiro; Marcus N da Gama; Pedro E Horta; Luiz J Kajita; Antonio Esteves; Marco A Perin; Paulo R Soares; Silvio Zalc; Igor F Palacios
Journal:  Catheter Cardiovasc Interv       Date:  2002-03       Impact factor: 2.692

9.  Effect of progression of left ventricular hypertrophy on coronary artery dimensions in aortic valve disease.

Authors:  B Villari; O M Hess; D Moccetti; G Vassalli; H P Krayenbuehl
Journal:  J Am Coll Cardiol       Date:  1992-11-01       Impact factor: 24.094

10.  Paradoxic decreases in atherosclerotic plaque mass in insulin-treated diabetic patients.

Authors:  R Kornowski; G S Mintz; A J Lansky; M K Hong; K M Kent; A D Pichard; L F Satler; J J Popma; T A Bucher; M B Leon
Journal:  Am J Cardiol       Date:  1998-06-01       Impact factor: 2.778

View more
  5 in total

1.  Adult height and risk of ischemic heart disease, atrial fibrillation, stroke, venous thromboembolism, and premature death: a population based 36-year follow-up study.

Authors:  Morten Schmidt; Hans Erik Bøtker; Lars Pedersen; Henrik Toft Sørensen
Journal:  Eur J Epidemiol       Date:  2013-12-14       Impact factor: 8.082

2.  Adult height, coronary heart disease and stroke: a multi-locus Mendelian randomization meta-analysis.

Authors:  Eveline Nüesch; Caroline Dale; Tom M Palmer; Jon White; Brendan J Keating; Erik Pa van Iperen; Anuj Goel; Sandosh Padmanabhan; Folkert W Asselbergs; W M Verschuren; C Wijmenga; Y T Van der Schouw; N C Onland-Moret; Leslie A Lange; G K Hovingh; Suthesh Sivapalaratnam; Richard W Morris; Peter H Whincup; Goya S Wannamethe; Tom R Gaunt; Shah Ebrahim; Laura Steel; Nikhil Nair; Alexander P Reiner; Charles Kooperberg; James F Wilson; Jennifer L Bolton; Stela McLachlan; Jacqueline F Price; Mark Wj Strachan; Christine M Robertson; Marcus E Kleber; Graciela Delgado; Winfried März; Olle Melander; Anna F Dominiczak; Martin Farrall; Hugh Watkins; Maarten Leusink; Anke H Maitland-van der Zee; Mark Ch de Groot; Frank Dudbridge; Aroon Hingorani; Yoav Ben-Shlomo; Debbie A Lawlor; A Amuzu; M Caufield; A Cavadino; J Cooper; T L Davies; F Drenos; J Engmann; C Finan; C Giambartolomei; R Hardy; S E Humphries; E Hypponen; M Kivimaki; D Kuh; M Kumari; K Ong; V Plagnol; C Power; M Richards; S Shah; T Shah; R Sofat; P J Talmud; N Wareham; H Warren; J C Whittaker; A Wong; D Zabaneh; George Davey Smith; Jonathan C Wells; David A Leon; Michael V Holmes; Juan P Casas
Journal:  Int J Epidemiol       Date:  2016-12-01       Impact factor: 7.196

3.  Association of taller stature with lower cardiovascular disease mortality in Asian people: a systematic review.

Authors:  Hiroyuki Teraura; Tatsuya Suzuki; Kazuhiko Kotani
Journal:  J Physiol Anthropol       Date:  2019-06-07       Impact factor: 2.867

4.  Mendelian randomisation analyses find pulmonary factors mediate the effect of height on coronary artery disease.

Authors:  Eirini Marouli; M Fabiola Del Greco; Christina M Astley; Jian Yang; Shafqat Ahmad; Sonja I Berndt; Mark J Caulfield; Evangelos Evangelou; Barbara McKnight; Carolina Medina-Gomez; Jana V van Vliet-Ostaptchouk; Helen R Warren; Zhihong Zhu; Joel N Hirschhorn; Ruth J F Loos; Zoltan Kutalik; Panos Deloukas
Journal:  Commun Biol       Date:  2019-03-27

5.  Adult height and risk of 50 diseases: a combined epidemiological and genetic analysis.

Authors:  Florence Y Lai; Mintu Nath; Stephen E Hamby; John R Thompson; Christopher P Nelson; Nilesh J Samani
Journal:  BMC Med       Date:  2018-10-25       Impact factor: 8.775

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.